Fasting serum fructose is associated with metabolic dysfunction-associated fatty liver disease: A prospective study.

Yujuan FanYuecheng ZhangCongling ChenZhen YingQing SuXiaoying LiYing Chen

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2023)

Fasting serum fructose concentration, which mostly reflects endogenous fructose, was associated with a higher risk of MAFLD. The FFI derived from fasting serum fructose could be used to predict MAFLD.

Keyphrases

blood glucose
insulin resistance
oxidative stress
metabolic syndrome
weight loss
glycemic control